Base to Base biotech podcast 68: Water from air for pharma and beyond
New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
Positive phase III results for idiopathic nephrotic syndrome drug
A new era in Alzheimer’s therapy?
China’s first AI drug completes phase III trial
Hopes for anti-ulcer vaccine
Lilly to acquire Adverum Biotechnologies
Advances in cell therapy for Huntington’s disease treatment
Custom-designed receptors boost cancer-fighting T cells
Promise for early Parkinson’s detection analysis